Tandem Diabetes Care Sees 2026 International Sales of $335M-$340M
Tandem Diabetes Care expects international sales of approximately $335 million to $340 million in 2026.
Related stories
Viant Shares Fall 15% After Third-Quarter Earnings Miss
Viant Technology shares fell 15% to $11.93 in Tuesday afternoon trading after the advertising company reported third-quarter adjusted earnings below analyst expectations.
M impact | EARNINGS | Nov 10, 2026, 06:29 PM UTC
Cotton Falls From 2-Week High
Cotton futures fell below 79 cents per pound, after reaching its highest level in two weeks, as traders weighed a lower global supply outlook and signs of improving export demand a
L impact | EARNINGS | Nov 10, 2026, 06:07 PM UTC
European Stocks Extend Rebound
European stocks closed higher for a second session on Tuesday as banks and technology stocks extended their gains. The Euro STOXX 50 added 0.7% to 6,337 and the STOXX Europe 600 ro
H impact | EARNINGS | Nov 10, 2026, 05:10 PM UTC
Lån & Spar Bank Raises 2026 After-Tax Profit Guidance
The bank increased its 2026 result-after-tax guidance to DKK 425–475 million from DKK 300–400 million.
M impact | EARNINGS | Nov 10, 2026, 04:32 PM UTC
Rice Futures Hover Around 2024-Highs
Rice prices eased to around $17.2 per hundredweight amid profit-taking, but remained close to their highest level since June 2024. Concerns over global supply persist, with El Niño
L impact | EARNINGS | Nov 10, 2026, 04:06 PM UTC
TSX Falls as Mining Stocks Dip
The S&P/TSX Composite fell nearly 1% to hover near 36,000 on Tuesday as declining gold prices pressured mining stocks. Gold fell sharply on hotter-than-expected US inflation and ha
H impact | EARNINGS | Nov 10, 2026, 03:03 PM UTC